We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Fundus Autofluorescence Patterns in Stargardt Disease Over Time—Reply

Catherine A. Cukras, MD, PhD; Wai T. Wong, MD, PhD; Rafael Caruso, MD; Denise Cunningham, MS; Wadih Zein, MD; Paul Sieving, MD
Arch Ophthalmol. 2012;130(10):1354-1355. doi:10.1001/archophthalmol.2012.2008.
Text Size: A A A
Published online


In reply

We agree with Smith that the subject of hyperautofluorescent changes in Stargardt disease is an interesting one that may be illuminating to understanding underlying disease pathophysiology. In our report, we had examined longitudinal changes in fundus autofluorescence over a series of time points in a number of affected eyes. Our observations describe a consistent pattern of temporal and spatial progression in the flecks associated with Stargardt disease. The general pattern was one in which brighter hyperautofluorescent flecks move centrifugally from the center of the macula. As these flecks move outward, they leave in their wake darker, hypoautofluorescent lesions. As a result, fundus autofluorescence at a particular point in the fleck's path may be described to be first increasing with time, becoming increasingly hyperautofluorescent relative to background, then decreasing back to background levels, and subsequently decreasing further to become hypoautofluorescent relative to background. We agree with Smith that within the time of our study (11-57 months), we did not observe further decreases in fundus autofluorescence in the tracks left behind by progressing flecks that may be described as frank atrophy (ie, the confluent absence of autofluorescence signal suggestive of retinal pigment epithelial cell loss).


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





October 1, 2012
R. Theodore Smith, MD, PhD
Arch Ophthalmol. 2012;130(10):1354-1355. doi:10.1001/archophthalmol.2012.1559.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.